How telemedicine can improve the quality of care for patients with alzheimer’s disease and related dementias? A narrative review

dc.authorid0000-0002-8584-5488
dc.contributor.authorAngelopoulou, Efthalia
dc.contributor.authorPapachristou, Nikolaos
dc.contributor.authorBougea, Anastasia
dc.contributor.authorStanitsa, Evangelia
dc.contributor.authorKontaxopoulou, Dionysia
dc.contributor.authorFragkiadaki, Stella
dc.contributor.authorPavlou, Dimosthenis
dc.contributor.authorKoros, Christos
dc.contributor.authorDeğirmenci, Yıldız
dc.contributor.authorPapatriantafyllou, John
dc.contributor.authorThireos, Eleftherios
dc.contributor.authorPolitis, Antonios
dc.contributor.authorTsouros, Agis
dc.contributor.authorBamidis, Panagiotis
dc.contributor.authorStefanis, Leonidas
dc.contributor.authorPapageorgiou, Sokratis
dc.date.accessioned2023-01-09T09:30:06Z
dc.date.available2023-01-09T09:30:06Z
dc.date.issued2022
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Nöroloji Ana Bilim Dalı
dc.description.abstractBackground and Objectives: Dementia affects more than 55 million patients worldwide, with a significant societal, economic, and psychological impact. However, many patients with Alzheimer’s disease (AD) and other related dementias have limited access to effective and individualized treatment. Care provision for dementia is often unequal, fragmented, and inefficient. The COVID-19 pandemic accelerated telemedicine use, which holds promising potential for addressing this important gap. In this narrative review, we aim to analyze and discuss how telemedicine can improve the quality of healthcare for AD and related dementias in a structured manner, based on the seven dimensions of healthcare quality defined by the World Health Organization (WHO), 2018: effectiveness, safety, people-centeredness, timeliness, equitability, integrated care, and efficiency. Materials and Methods: MEDLINE and Scopus databases were searched for peer-reviewed articles investigating the role of telemedicine in the quality of care for patients with dementia. A narrative synthesis was based on the seven WHO dimensions. Results: Most studies indicate that telemedicine is a valuable tool for AD and related dementias: it can improve effectiveness (better access to specialized care, accurate diagnosis, evidence-based treatment, avoidance of preventable hospitalizations), timeliness (reduction of waiting times and unnecessary transportation), patient-centeredness (personalized care for needs and values), safety (appropriate treatment, reduction of infection risk),integrated care (interdisciplinary approach through several dementia-related services), efficiency (mainly cost-effectiveness) and equitability (overcoming geographical barriers, cultural diversities). However, digital illiteracy, legal and organizational issues, as well as limited awareness, are significant potential barriers. Conclusions: Telemedicine may significantly improve all aspects of the quality of care for patients with dementia. However, future longitudinal studies with control groups including participants of a wide educational level spectrum will aid in our deeper understanding of the real impact of telemedicine in quality care for this population.
dc.identifier.citationAngelopoulou, E., Papachristou, N., Bougea, A., Stanitsa, E., Kontaxopoulou, D., Fragkiadaki, S. ... Papageorgiou, S. (2022). How telemedicine can improve the quality of care for patients with alzheimer’s disease and related dementias? A narrative review. Medicina (Lithuania), 58(12). https://dx.doi.org/10.3390/medicina58121705
dc.identifier.doi10.3390/medicina58121705
dc.identifier.issn1010-660X
dc.identifier.issn1648-9144
dc.identifier.issue12
dc.identifier.pmid36556907
dc.identifier.scopus2-s2.0-85144490089
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://dx.doi.org/10.3390/medicina58121705
dc.identifier.urihttps://hdl.handle.net/20.500.12511/10266
dc.identifier.volume58
dc.identifier.wos000902805200001en_US
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorDeğirmenci, Yıldız
dc.language.isoen
dc.publisherMDPI
dc.relation.ispartofMedicina (Lithuania)en_US
dc.relation.publicationcategoryDiğer
dc.rightsAttribution 4.0 International*
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectAlzheimer’s Disease (AD)
dc.subjectCOVID-19
dc.subjectTelemedicine
dc.subjectWorld Health Organization (WHO)
dc.titleHow telemedicine can improve the quality of care for patients with alzheimer’s disease and related dementias? A narrative review
dc.typeReview Article

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Degirmenci-Yildiz-2022.pdf
Boyut:
741.09 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: